Indexed keywords
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
ANTINUCLEAR ANTIBODY;
CHLOROQUINE;
DOUBLE STRANDED DNA ANTIBODY;
HYDROXYCHLOROQUINE;
PHOSPHOLIPID ANTIBODY;
SM ANTIBODY;
VITAMIN D;
ANTIBODY DETECTION;
ANTIBODY TITER;
ARTICLE;
DISEASE EXACERBATION;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG UTILIZATION;
HIGH RISK PATIENT;
HUMAN;
IMMUNOASSAY;
LOW DRUG DOSE;
NONHUMAN;
PREGNANCY COMPLICATION;
PRIMARY PREVENTION;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SECONDARY PREVENTION;
SMOKING;
SYSTEMIC LUPUS ERYTHEMATOSUS;
THROMBOEMBOLISM;
THROMBOSIS PREVENTION;
TREATMENT RESPONSE;
BLOOD;
IMMUNOLOGY;
METHODOLOGY;
ANTIBODIES, ANTINUCLEAR;
ANTIBODIES, ANTIPHOSPHOLIPID;
HUMANS;
LUPUS ERYTHEMATOSUS, SYSTEMIC;
PRIMARY PREVENTION;
THROMBOEMBOLISM;
1
33746406072
Long-term prognosis and causes of death in systemic lupus erythematosus
Doria A et al. (2006) Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 119: 700-706
(2006)
Am J Med , vol.119
, pp. 700-706
Doria, A.1
2
10444231093
Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological and psychological determinants
Doria A et al. (2004) Health-related quality of life in Italian patients with systemic lupus erythematosus. II. Role of clinical, immunological and psychological determinants. Rheumatology (Oxford 43: 1580-1586
(2004)
Rheumatology (Oxford , vol.43
, pp. 1580-1586
Doria, A.1
3
42549093135
Lupus: Improving long-term prognosis
Doria A and Briani C (2008) Lupus: Improving long-term prognosis. Lupus 17: 166-170
(2008)
Lupus , vol.17
, pp. 166-170
Doria, A.1
Briani, C.2
4
37649009030
Preventive strategies in systemic lupus erythematosus
Doria A et al. (2008) Preventive strategies in systemic lupus erythematosus. Autoimmun Rev 7: 192-197
(2008)
Autoimmun Rev , vol.7
, pp. 192-197
Doria, A.1
5
34547208786
Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus
James JA et al. (2007) Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus. Lupus 16: 401-409
(2007)
Lupus , vol.16
, pp. 401-409
James, J.A.1
6
34247155191
Vaccination and rheumatic diseases: Is there still a dilemma?
Conti F et al. (2007) Vaccination and rheumatic diseases: Is there still a dilemma? Curr Rheumatol Rev 3: 79-91
(2007)
Curr Rheumatol Rev , vol.3
, pp. 79-91
Conti, F.1
7
68349149742
Challenges of lupus pregnancies
Doria A et al. (2008) Challenges of lupus pregnancies. Rheumatology (Oxford) 47 (Suppl 3): Iii9-iii12
(2008)
Rheumatology (Oxford) , vol.47
, Issue.SUPPL. 3
Doria, A.1
8
34548150136
Vitamin D and autoimmunity: New aetiological and therapeutic considerations
Arnson Y et al. (2007) Vitamin D and autoimmunity: New aetiological and therapeutic considerations. Ann Rheum Dis 66 1137-1142
(2007)
Ann Rheum Dis , vol.66
, pp. 1137-1142
Arnson, Y.1
9
33750297108
Antimalarial agents: Closing the gate on Toll-like receptors?
Lafyatis R et al. (2006) Antimalarial agents: Closing the gate on Toll-like receptors? Arthritis Rheum 54: 3068-3070
(2006)
Arthritis Rheum , vol.54
, pp. 3068-3070
Lafyatis, R.1
10
33750369226
Toll-like receptors in systemic autoimmune disease
Marshak-Rothstein A (2006) Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol 6: 823-835
(2006)
Nat Rev Immunol , vol.6
, pp. 823-835
Marshak-Rothstein, A.1
11
34250173118
Anti-prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: A 15-year longitudinal study
Bizzarro N et al. (2007) Anti-prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: A 15-year longitudinal study. J Thromb Haemost 5: 1158-1164
(2007)
J Thromb Haemost , vol.5
, pp. 1158-1164
Bizzarro, N.1
12
33644606069
Management of antiphospholipid antibody syndrome: A systematic review
Lim W et al. (2006) Management of antiphospholipid antibody syndrome: A systematic review. JAMA 295: 1050-1057
(2006)
JAMA , vol.295
, pp. 1050-1057
Lim, W.1
